Structure, function, and pharmacology of NMDA receptor channels

Physiological Research

Volumn 63, Issue SUPPL., 2014, Pages

  Vyklicky, V ^a   Korinek, M ^a   Smejkalova, T ^a   Balik, A ^a   Krausova, B ^a   Kaniakova, M ^a   Lichnerova, K ^a   Cerny, J ^a   Krusek, J ^a   Dittert, I ^a   Horak, M ^a   Vyklicky, L ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Channel blocker; Glutamate receptor; Ion channel; NMDA receptor; Pharmacology; Synaptic transmission

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT;

ANIMAL; BRAIN; BRAIN DISEASE; CHANNEL GATING; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; NERVE CELL; PROTEIN CONFORMATION; REVIEW; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION; ULTRASTRUCTURE;

ANIMALS; BRAIN; BRAIN DISEASES; HUMANS; ION CHANNEL GATING; NEURONS; NEUROPROTECTIVE AGENTS; PROTEIN CONFORMATION; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTIC TRANSMISSION;

EID: 84897608820     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. ACKER TM, YUAN H, HANSEN KB, VANCE KM, OGDEN KK, JENSEN HS, BURGER PB, MULLASSERIL P, SNYDER JP, LIOTTA DC, TRAYNELIS SF, Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators. Mol Pharmacol 80, 782-795, 2011.
2. AMICO-RUVIO SA, POPESCU GK, Stationary gating of GluN1/GluN2B receptors in intact membrane patches. Biophys J 98, 1160-1169, 2010.
3. AMICO-RUVIO SA, PAGANELLI MA, MYERS JM, POPESCU GK, Ifenprodil effects on GluN2B-containing glutamate receptors. Mol Pharmacol 82, 1074-1081, 2012.
4. ANIS N, SHERBY S, GOODNOW R JR, NIWA M, KONNO K, KALLIMOPOULOS T, BUKOWNIK R, NAKANISHI K, USHERWOOD P, ELDEFRAWI A, ELDEFRAWI M, Structure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptors.J Pharmacol Exp Ther 254, 764-773, 1990.
5. ARMSTRONG N, GOUAUX E, Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor, crystal structures of the GluR2 ligand binding core. Neuron 28, 165-181, 2000.
6. BANKE TG, TRAYNELIS SF, Activation of NR1/NR2B NMDA receptors. Nat Neurosci 6, 144-152, 2003.
7. BENVENISTE M, MAYER ML, Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine. Biophys J 59, 560-573, 1991.
8. BENVENISTE M, CLEMENTS J, VYKLICKY L JR, MAYER ML, A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones. J Physiol 428, 333-357, 1990.
9. BERGLES DE, DIAMOND JS, JAHR CE, Clearance of glutamate inside the synapse and beyond. Curr Opin Neurobiol 9, 293-298, 1999.
10. BETTINI E, SAVA A, GRIFFANTE C, CARIGNANI C, BUSON A, CAPELLI AM, NEGRI M, ANDREETTA F, SENAR-SANCHO SA, GUIRAL L, CARDULLO F, Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. J Pharmacol Exp Ther 335, 636-644, 2010.
11. BOROVSKA J, VYKLICKY V, STASTNA E, KAPRAS V, SLAVIKOVA B, HORAK M, CHODOUNSKA H, VYKLICKY L JR, Access of inhibitory neurosteroids to the NMDA receptor. Br J Pharmacol 166, 1069-1083, 2012.
12. BURNASHEV N, MONYER H, SEEBURG PH, SAKMANN B, Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8, 189-198, 1992a.
13. BURNASHEV N, SCHOEPFER R, MONYER H, RUPPERSBERG JP, GUNTHER W, SEEBURG PH, SAKMANN B, Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science 257, 1415-1419, 1992b.
14. CAIS O, SEDLACEK M, HORAK M, DITTERT I, VYKLICKY L JR, Temperature dependence of NR1/NR2B NMDA receptor channels. Neuroscience 151, 428-438, 2008.
15. CHATTERTON JE, AWOBULUYI M, PREMKUMAR LS, TAKAHASHI H, TALANTOVA M, SHIN Y, CUI J, TU S, SEVARINO KA, NAKANISHI N, TONG G, LIPTON SA, ZHANG D, Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415, 793-798, 2002.
16. CHEN HS, LIPTON SA, Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels. J Pharmacol Exp Ther 314, 961-971, 2005.
17. CHEN PE, GEBALLE MT, KATZ E, ERREGER K, LIVESEY MR, O'TOOLE KK, LE P, LEE CJ, SNYDER JP, TRAYNELIS SF, WYLLIE DJ, Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J Physiol 586, 227-245, 2008.
18. CHIU J, DESALLE R, LAM HM, MEISEL L, CORUZZI G, Molecular evolution of glutamate receptors, a primitive signaling mechanism that existed before plants and animals diverged. Mol Biol Evol 16, 826-838, 1999.
19. CLARK GD, CLIFFORD DB, ZORUMSKI CF, The effect of agonist concentration, membrane voltage and calcium on N-methyl-D-aspartate receptor desensitization. Neuroscience 39, 787-797, 1990.
20. CLEMENTS JD, WESTBROOK GL, Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor. Neuron 7, 605-613, 1991.
21. COSTA BM, FENG B, TSINTSADZE TS, MORLEY RM, IRVINE MW, TSINTSADZE V, LOZOVAYA NA, JANE DE, MONAGHAN DT, N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives, preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. J Pharmacol Exp Ther 331, 618-626, 2009.
22. COSTA BM, IRVINE MW, FANG G, EAVES RJ, MAYO-MARTIN MB, SKIFTER DA, JANE DE, MONAGHAN DT, A novel family of negative and positive allosteric modulators of NMDA receptors. J Pharmacol Exp Ther 335, 614-621, 2010.
23. COSTA BM, IRVINE MW, FANG G, EAVES RJ, MAYO-MARTIN MB, LAUBE B, JANE DE, MONAGHAN DT, Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid. Neuropharmacology 62, 1730-1736, 2012.
24. DRAVID SM, ERREGER K, YUAN H, NICHOLSON K, LE P, LYUBOSLAVSKY P, ALMONTE A, MURRAY E, MOSELY C, BARBER J, FRENCH A, BALSTER R, MURRAY TF, TRAYNELIS SF, Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block. J Physiol 581, 107-128, 2007.
25. DRAVID SM, PRAKASH A, TRAYNELIS SF, Activation of recombinant NR1/NR2C NMDA receptors. J Physiol 586, 4425-4439, 2008.
26. ERREGER K, DRAVID SM, BANKE TG, WYLLIE DJ, TRAYNELIS SF, Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol 563, 345-358, 2005.
27. ERREGER K, GEBALLE MT, KRISTENSEN A, CHEN PE, HANSEN KB, LEE CJ, YUAN H, LE P, LYUBOSLAVSKY PN, MICALE N, JORGENSEN L, CLAUSEN RP, WYLLIE DJ, SNYDER JP, TRAYNELIS SF, Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors. Mol Pharmacol 72, 907-920, 2007.
28. FENG B, MORLEY RM, JANE DE, MONAGHAN DT, The effect of competitive antagonist chain length on NMDA receptor subunit selectivity. Neuropharmacology 48, 354-359, 2005.
29. FURUKAWA H, SINGH SK, MANCUSSO R, GOUAUX E, Subunit arrangement and function in NMDA receptors. Nature 438, 185-192, 2005.
30. GILLING KE, JATZKE C, HECHENBERGER M, PARSONS CG, Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors. Neuropharmacology 56, 866-875, 2009.
31. HANSEN KB, TRAYNELIS SF, Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors. J Neurosci 31, 3650-3661, 2011.
32. HANSEN KB, OGDEN KK, TRAYNELIS SF, Subunit-selective allosteric inhibition of glycine binding to NMDA receptors. J Neurosci 32, 6197-6208, 2012.
33. HEINRICH A, ANDO RD, TURI G, ROZSA B, SPERLAGH B, K+ depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus, a microelectrode biosensor study. Br J Pharmacol 167, 1003-1020, 2012.
34. HERMAN MA, JAHR CE, Extracellular glutamate concentration in hippocampal slice. J Neurosci 27, 9736-9741, 2007.
35. HERMAN MA, NAHIR B, JAHR CE, Distribution of extracellular glutamate in the neuropil of hippocampus. PLoS One 6, e26501, 2011.
36. HORAK M, VLCEK K, PETROVIC M, CHODOUNSKA H, VYKLICKY L JR, Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors. J Neurosci 24, 10318-10325, 2004.
37. HORAK M, VLCEK K, CHODOUNSKA H, VYKLICKY L JR, Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate. Neuroscience 137, 93-102, 2006.
38. IIJIMA K, TAKASE S, TSUMURAYA K, ENDO M, ITAHARA K, Changes in free amino acids of cerebrospinal fluid and plasma in various neurological diseases. Tohoku J Exp Med 126, 133-150, 1978.
39. JANG MK, MIERKE DF, RUSSEK SJ, FARB DH, A steroid modulatory domain on NR2B controls N-methyl-Daspartate receptor proton sensitivity. Proc Natl Acad Sci USA 101, 8198-8203, 2004.
40. JIANG Y, LEE A, CHEN J, CADENE M, CHAIT BT, MACKINNON R, The open pore conformation of potassium channels. Nature 417, 523-526, 2002.
41. JOHNSON JW, ASCHER P, Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529-531, 1987.
42. JOHNSON JW, KOTERMANSKI SE, Mechanism of action of memantine. Curr Opin Pharmacol 6, 61-67, 2006.
43. KALIA LV, KALIA SK, SALTER MW, NMDA receptors in clinical neurology, excitatory times ahead. Lancet Neurol 7, 742-755, 2008.
44. KARAKAS E, SIMOROWSKI N, FURUKAWA H, Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature 475, 249-253, 2011.
45. KINARSKY L, FENG B, SKIFTER DA, MORLEY RM, SHERMAN S, JANE DE, MONAGHAN DT, Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamatebinding pocket. J Pharmacol Exp Ther 313, 1066-1074, 2005.
46. KLECKNER NW, DINGLEDINE R, Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241, 835-837, 1988.
47. KOHLER M, BURNASHEV N, SAKMANN B, SEEBURG PH, Determinants of Ca2+ permeability in both TM1 and TM2 of high affinity kainate receptor channels, diversity by RNA editing. Neuron 10, 491-500, 1993.
48. KORINEK M, SEDLACEK M, CAIS O, DITTERT I, VYKLICKY L JR, Temperature dependence of N-methyl-Daspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents. Neuroscience 165, 736-748, 2010.
49. KORNHUBER J, WELLER M, Psychotogenicity and N-methyl-D-aspartate receptor antagonism, implications for neuroprotective pharmacotherapy. Biol Psychiatry 41, 135-144, 1997.
50. KOTERMANSKI SE, JOHNSON JW, Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine. J Neurosci 29, 2774-2779, 2009.
51. LEGENDRE P, WESTBROOK GL, Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Mol Pharmacol 40, 289-298, 1991.
52. LESTER RA, JAHR CE, NMDA channel behavior depends on agonist affinity. J Neurosci 12, 635-643, 1992.
53. LODGE D, JOHNSON KM, Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11, 81-86, 1990.
54. LOMELI H, MOSBACHER J, MELCHER T, HOGER T, GEIGER JR, KUNER T, MONYER H, HIGUCHI M, BACH A, SEEBURG PH, Control of kinetic properties of AMPA receptor channels by nuclear RNA editing Science 266, 1709-1713, 1994
55. LONG SB, TAO X, CAMPBELL EB, MACKINNON R, Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature 450, 376-382, 2007.
56. MADDEN DR, The structure and function of glutamate receptor ion channels. Nat Rev Neurosci 3, 91-101, 2002.
57. MALAYEV A, GIBBS TT, FARB DH, Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br J Pharmacol 135, 901-909, 2002.
58. MALENKA RC, NICOLL RA, Long-term potentiation - a decade of progress? Science 285, 1870-1874, 1999
59. MATTSON MP, Excitotoxic and excitoprotective mechanisms, abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 3, 65-94, 2003.
60. MAYER ML, Crystal structures of the GluR5 and GluR6 ligand binding cores, molecular mechanisms underlying kainate receptor selectivity. Neuron 45, 539-552, 2005.
61. MAYER ML, Glutamate receptors at atomic resolution. Nature 440, 456-462, 2006.
62. MAYER ML, WESTBROOK GL, Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J Physiol 394, 501-527, 1987.
63. MAYER ML, VYKLICKY L JR, CLEMENTS J, Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 338, 425-427, 1989.
64. MAYER ML, ARMSTRONG N, Structure and function of glutamate receptor ion channels. Annu Rev Physiol 66, 161-181, 2004.
65. MIDGETT CR, GILL A, MADDEN DR, Domain architecture of a calcium-permeable AMPA receptor in a ligand-free conformation. Front Mol Neurosci 4, 56, 2012.
66. MONY L, ZHU S, CARVALHO S, PAOLETTI P, Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines. Embo J 30, 3134-3146, 2011.
67. MONYER H, SPRENGEL R, SCHOEPFER R, HERB A, HIGUCHI M, LOMELI H, BURNASHEV N, SAKMANN B, SEEBURG PH, Heteromeric NMDA receptors, molecular and functional distinction of subtypes. Science 256, 1217-1221, 1992.
68. MORIYOSHI K, MASU M, ISHII T, SHIGEMOTO R, MIZUNO N, NAKANISHI S, Molecular cloning and characterization of the rat NMDA receptor. Nature 354, 31-37, 1991.
69. MORLEY RM, TSE HW, FENG B, MILLER JC, MONAGHAN DT, JANE DE, Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists. J Med Chem 48, 2627-2637, 2005.
70. MOSLEY CA, ACKER TM, HANSEN KB, MULLASSERIL P, ANDERSEN KT, LE P, VELLANO KM, BRAUNER-OSBORNE H, LIOTTA DC, TRAYNELIS SF, Quinazolin-4-one derivatives, A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. J Med Chem 53, 5476-5490, 2010.
71. MULLASSERIL P, HANSEN KB, VANCE KM, OGDEN KK, YUAN H, KURTKAYA NL, SANTANGELO R, ORR AG, LE P, VELLANO KM, LIOTTA DC, TRAYNELIS SF, A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. Nat Commun 1, 90, 2010.
72. NYITRAI G, KEKESI KA, JUHASZ G, Extracellular level of GABA and Glu, in vivo microdialysis-HPLC measurements. Curr Top Med Chem 6, 935-940, 2006.
73. OGDEN KK, TRAYNELIS SF, Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptors. Mol Pharmacol 83, 1045-1056, 2013.
74. PACHERNEGG S, STRUTZ-SEEBOHM N, HOLLMANN M, GluN3 subunit-containing NMDA receptors, not just one-trick ponies. Trends Neurosci 35, 240-249, 2012.
75. PAPOUIN T, LADEPECHE L, RUEL J, SACCHI S, LABASQUE M, HANINI M, GROC L, POLLEGIONI L, MOTHET JP, OLIET SH, Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell 150, 633-646, 2012.
76. PARK-CHUNG M, WU FS, PURDY RH, MALAYEV AA, GIBBS TT, FARB DH, Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids. Mol Pharmacol 52, 1113-1123, 1997.
77. PATNEAU DK, MAYER ML, Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci 10, 2385-2399, 1990.
78. PETROVIC M, SEDLACEK M, HORAK M, CHODOUNSKA H, VYKLICKY L JR, 20-oxo-5beta-pregnan-3alpha-yl sulfate is a use-dependent NMDA receptor inhibitor. J Neurosci 25, 8439-8450, 2005.
79. PETROVIC M, SEDLACEK M, CAIS O, HORAK M, CHODOUNSKA H, VYKLICKY L JR, Pregnenolone sulfate modulation of N-methyl-D-aspartate receptors is phosphorylation dependent. Neuroscience 160, 616-628, 2009.
80. PHILLIS JW, O'REGAN MH, Characterization of modes of release of amino acids in the ischemic/reperfused rat cerebral cortex. Neurochem Int 43, 461-467, 2003.
81. POPESCU G, AUERBACH A, Modal gating of NMDA receptors and the shape of their synaptic response. Nat Neurosci 6, 476-483, 2003.
82. SOBOLEVSKY AI, BECK C, WOLLMUTH LP, Molecular rearrangements of the extracellular vestibule in NMDAR channels during gating. Neuron 33, 75-85, 2002.
83. SOBOLEVSKY AI, PRODROMOU ML, YELSHANSKY MV, WOLLMUTH LP, Subunit-specific contribution of pore-forming domains to NMDA receptor channel structure and gating. J Gen Physiol 129, 509-525, 2007.
84. SOBOLEVSKY AI, ROSCONI MP, GOUAUX E, X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462, 745-756, 2009.
85. SUGIHARA H, MORIYOSHI K, ISHII T, MASU M, NAKANISHI S, Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem Biophys Res Commun 185, 826-832, 1992.
86. TRAYNELIS SF, HARTLEY M, HEINEMANN SF, Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268, 873-876, 1995.
87. TRAYNELIS SF, WOLLMUTH LP, MCBAIN CJ, MENNITI FS, VANCE KM, OGDEN KK, HANSEN KB, YUAN H, MYERS SJ, DINGLEDINE R, Glutamate receptor ion channels, structure, regulation, and function. Pharmacol Rev 62, 405-496, 2010.
88. ULBRICH MH, ISACOFF EY, Rules of engagement for NMDA receptor subunits. Proc Natl Acad Sci USA 105, 14163-14168, 2008.
89. VANDER AJ, SHERMAN JH, LUCIANO DS, Human physiology, the mechanism of body function. McGraw-Hill, New York, 2001, pp 129, 184.
90. VILLARROEL A, REGALADO MP, LERMA J, Glycine-independent NMDA receptor desensitization, localization of structural determinants. Neuron 20, 329-339, 1998.
91. VYKLICKY L JR, Calcium-mediated modulation of N-methyl-D-aspartate (NMDA) responses in cultured rat hippocampal neurones. J Physiol 470, 575-600, 1993.
92. WATKINS JC, EVANS RH, Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 21, 165-204, 1981.
93. WILLIAMS K, Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor, selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44, 851-859, 1993.
94. WILLIAMS K, DAWSON VL, ROMANO C, DICHTER MA, MOLINOFF PB, Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron 5, 199-208, 1990.
95. WONG EH, KEMP JA, PRIESTLEY T, KNIGHT AR, WOODRUFF GN, IVERSEN LL, The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83, 7104-7108, 1986.
96. WU FS, GIBBS TT, FARB DH, Pregnenolone sulfate, a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol 40, 333-336, 1991.
97. XIA P, CHEN HS, ZHANG D, LIPTON SA, Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci 30, 11246-11250, 2010.
98. ZUKIN RS, BENNETT MV, Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 18, 306-313, 1995.
99. ZUO J, DE JAGER PL, TAKAHASHI KA, JIANG W, LINDEN DJ, HEINTZ N, Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature 388, 769-773, 1997.